| Dr Apurva Ashok Shah, MD | |
|
123 Summer St # 587, Worcester, MA 01608-1216 | |
| (508) 363-6470 | |
| (508) 363-7470 |
| Full Name | Dr Apurva Ashok Shah |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 123 Summer St # 587, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194071969 | NPI | - | NPPES |
| 110114608A | Medicaid | MA | |
| 0135687 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 266066 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Hospital | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Vincent Physician Services Inc | 8921056276 | 75 |
News Archive
Obesity has more than doubled in children and tripled in adolescents in the United States in the past 30 years, according to the Centers for Disease Control and Prevention. The growing rate of childhood obesity is a major health concern since overweight and obese youth are at increased risk of developing several diseases once considered reserved for adults. These new pediatric diseases include type-2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, a condition in which fat builds up in the liver, potentially impairing its function over time.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
› Verified 7 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Obesity has more than doubled in children and tripled in adolescents in the United States in the past 30 years, according to the Centers for Disease Control and Prevention. The growing rate of childhood obesity is a major health concern since overweight and obese youth are at increased risk of developing several diseases once considered reserved for adults. These new pediatric diseases include type-2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, a condition in which fat builds up in the liver, potentially impairing its function over time.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
› Verified 7 days ago
| Entity Name | Saint Vincent Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013997329 PECOS PAC ID: 8921056276 Enrollment ID: O20050104000566 |
News Archive
Obesity has more than doubled in children and tripled in adolescents in the United States in the past 30 years, according to the Centers for Disease Control and Prevention. The growing rate of childhood obesity is a major health concern since overweight and obese youth are at increased risk of developing several diseases once considered reserved for adults. These new pediatric diseases include type-2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, a condition in which fat builds up in the liver, potentially impairing its function over time.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
› Verified 7 days ago
| Entity Name | Obhg Massachusetts - Direct Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487229035 PECOS PAC ID: 1456752609 Enrollment ID: O20210625001903 |
News Archive
Obesity has more than doubled in children and tripled in adolescents in the United States in the past 30 years, according to the Centers for Disease Control and Prevention. The growing rate of childhood obesity is a major health concern since overweight and obese youth are at increased risk of developing several diseases once considered reserved for adults. These new pediatric diseases include type-2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, a condition in which fat builds up in the liver, potentially impairing its function over time.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Apurva Ashok Shah, MD 123 Summer Street, 587, Worcester, MA 01608-1216 Ph: (508) 363-6470 | Dr Apurva Ashok Shah, MD 123 Summer St # 587, Worcester, MA 01608-1216 Ph: (508) 363-6470 |
News Archive
Obesity has more than doubled in children and tripled in adolescents in the United States in the past 30 years, according to the Centers for Disease Control and Prevention. The growing rate of childhood obesity is a major health concern since overweight and obese youth are at increased risk of developing several diseases once considered reserved for adults. These new pediatric diseases include type-2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, a condition in which fat builds up in the liver, potentially impairing its function over time.
A collaboration between the Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) to spur the fight against neglected diseases has been established.
Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy.
› Verified 7 days ago
Benjamin D. Hamar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-0550 Fax: 508-334-8412 | |
Tara J. Chute, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-1000 | |
Isabel Karlins Sausjord, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Belmont St Apt 401, Worcester, MA 01605 Phone: 508-334-6388 | |
Leah Wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 328 Shrewsbury St, Ste 100, Worcester, MA 01604 Phone: 508-755-4861 Fax: 508-752-1392 | |
Mr. Donald James Desio, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 123 Summer St, Suite 150 S, Worcester, MA 01608 Phone: 508-368-3110 Fax: 508-368-3113 | |
Anne E. Garrison, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-6255 | |
Debra M Papa, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 33 Kendall St, Department Of Obstetrics & Gynecology, Worcester, MA 01605 Phone: 508-334-6255 Fax: 508-334-6063 |